Leadermed Health Group Limited

leadermed is a global, innovative biopharmaceutical company that leverages the asia-pacific market, expediting r&d cost-effectively; in addition to penetrating the apac market and bringing significant sales, we generate quality clinical data that can be used by partners to initiate phase 3 or pivotal trials elsewhere, such as the u.s. and emea; leadermed is developing first-in-class therapeutics in several diseases with significant unmet needs. the current company pipeline includes therapeutic candidates for: diabetes, obesity, hemophilia a and b, lung fibrosis, myocardial fibrosis, and scar-less wound healing. headquartered in the u.s. and with operations and manufacturing capabilities in korea, singapore and china, leadermed is led by a veteran executive team featuring decades of collective expertise in the full lifecycle of drug development.